Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.

Chen G, Pan SQ, Shen C, Pan SF, Zhang XM, He QY.

Acta Pharmacol Sin. 2014 Apr;35(4):463-75. doi: 10.1038/aps.2013.185. Epub 2014 Mar 10.

2.
3.

Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.

Wang AW, Song L, Miao J, Wang HX, Tian C, Jiang X, Han QY, Yu L, Liu Y, Du J, Xia YL, Li HH.

Am J Hypertens. 2015 Apr;28(4):518-26. doi: 10.1093/ajh/hpu194. Epub 2014 Oct 31.

PMID:
25362112
4.

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

Li HL, Wang AB, Huang Y, Liu DP, Wei C, Williams GM, Zhang CN, Liu G, Liu YQ, Hao DL, Hui RT, Lin M, Liang CC.

Free Radic Biol Med. 2005 Jan 15;38(2):243-57.

PMID:
15607907
5.

Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.

Bruder-Nascimento T, Chinnasamy P, Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC, Sibinga NE.

J Mol Cell Cardiol. 2014 Jan;66:18-26.

6.

Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, Pimentel DR, Sam F.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H984-93. doi: 10.1152/ajpheart.00428.2011. Epub 2011 Jun 10.

7.

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

Yin Z, Wang X, Zhang L, Zhou H, Wei L, Dong X.

Cardiovasc Ther. 2016 Feb;34(1):21-9. doi: 10.1111/1755-5922.12164.

PMID:
26506219
8.

α₁ adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway.

Yu X, Jia B, Wang F, Lv X, Peng X, Wang Y, Li H, Wang Y, Lu D, Wang H.

J Cell Mol Med. 2014 Feb;18(2):263-73. doi: 10.1111/jcmm.12184. Epub 2013 Dec 5.

9.

Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.

He Z, Zhang X, Chen C, Wen Z, Hoopes SL, Zeldin DC, Wang DW.

Cardiovasc Res. 2015 Mar 1;105(3):304-17. doi: 10.1093/cvr/cvv018. Epub 2015 Jan 24.

10.

ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts.

Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S.

Circ Res. 2001 Oct 12;89(8):661-9.

11.

Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species.

Takahashi M, Suzuki E, Takeda R, Oba S, Nishimatsu H, Kimura K, Nagano T, Nagai R, Hirata Y.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2879-88. doi: 10.1152/ajpheart.91406.2007. Epub 2008 Apr 25.

12.

Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.

Wang S, Han HM, Pan ZW, Hang PZ, Sun LH, Jiang YN, Song HX, Du ZM, Liu Y.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Aug;385(8):823-31. doi: 10.1007/s00210-012-0740-4. Epub 2012 May 9.

PMID:
22569796
13.
14.

Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy.

Wu QQ, Zong J, Gao L, Dai J, Yang Z, Xu M, Fang Y, Ma ZG, Tang QZ.

Herz. 2014 May;39(3):390-6. doi: 10.1007/s00059-013-3849-4. Epub 2013 Jun 21.

PMID:
23784363
15.

Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.

Yu L, She T, Li M, Shi C, Han L, Cheng M.

Int J Mol Med. 2013 Sep;32(3):717-22. doi: 10.3892/ijmm.2013.1436. Epub 2013 Jul 9.

PMID:
23842595
16.

Angiotensin II induces C-reactive protein expression via AT1-ROS-MAPK-NF-κB signal pathway in hepatocytes.

Zhao J, Liu J, Pang X, Wang S, Wu D, Zhang X, Feng L.

Cell Physiol Biochem. 2013;32(3):569-80. doi: 10.1159/000354461. Epub 2013 Sep 6.

17.

Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.

Shen DF, Tang QZ, Yan L, Zhang Y, Zhu LH, Wang L, Liu C, Bian ZY, Li H.

Br J Pharmacol. 2010 Feb;159(4):970-81. doi: 10.1111/j.1476-5381.2009.00605.x. Epub 2010 Jan 25.

18.

Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway.

Zhang J, Chen J, Yang J, Xu CW, Pu P, Ding JW, Jiang H.

Cell Physiol Biochem. 2013;31(2-3):230-41. doi: 10.1159/000343364. Epub 2013 Feb 14.

19.

Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.

Hu W, Li F, Mahavadi S, Murthy KS.

Am J Physiol Cell Physiol. 2009 Jun;296(6):C1310-20. doi: 10.1152/ajpcell.00573.2008. Epub 2009 Apr 15.

20.

Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.

Li HL, Huang Y, Zhang CN, Liu G, Wei YS, Wang AB, Liu YQ, Hui RT, Wei C, Williams GM, Liu DP, Liang CC.

Free Radic Biol Med. 2006 May 15;40(10):1756-75.

PMID:
16767845

Supplemental Content

Support Center